Partnership Opportunities

New partnership opportunities with NeoImmuneTech

NeoImmuneTech’s NT-I7(IL-7-hyFc) has broad applicability to many indications such as immuno-oncology, lymphopenia and HPV-induced diseases. NeoImmuneTech actively pursues collaboration or partnership with global leading research and development organizations and companies, to accelerate development process and efficiently expand the application of our products. Please feel free to contact us, if you have any idea of research and development or willing to have a collaboration/partnership with NeoImmuneTech.

For further information on partnership/collaboration contact:

Jaehan Park, Chief Strategy Officer

2200 Research Blvd., Suite 550
Rockville, MD 20850
T 240.801.9065
F 240.595.6132